Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?

Affiliations

Editorial

Zeev Blumenfeld. J Clin Oncol. 2018.

. 2018 Jul 1;36(19):1895-1897.

doi: 10.1200/JCO.2018.78.9347. Epub 2018 May 2.

No abstract available

Comment in

Reply to V. Turan et al.
Blumenfeld Z. Blumenfeld Z. J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8. J Clin Oncol. 2019. PMID: 30407896 No abstract available.
Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods.
Turan V, Bedoschi G, Rodriguez-Wallberg K, Sonmezer M, Pacheco FS, Oktem O, Taylor H, Oktay K. Turan V, et al. J Clin Oncol. 2019 Jan 1;37(1):84-86. doi: 10.1200/JCO.18.00420. Epub 2018 Nov 8. J Clin Oncol. 2019. PMID: 30407897 No abstract available.

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, Boni L, Unger JM, Anderson RA, Mehta K, Minton S, Poggio F, Albain KS, Adamson DJA, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge AH, Del Mastro L. Lambertini M, et al. J Clin Oncol. 2018 Jul 1;36(19):1981-1990. doi: 10.1200/JCO.2018.78.0858. Epub 2018 May 2. J Clin Oncol. 2018. PMID: 29718793 Free PMC article.